GlassScriptPhysician profile
Muhammad K Ishaq
NPI 1134449242
$4,750.02
in general payments reported to CMS, 2019-2025
22 companies · $919 in 2025
The $919 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $328 · 2023: $1,559 · 2024: $1,839 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,069 · Education: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,069.05 |
| Education | $247.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $905.01 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $763.88 | 2022-2025 | Ofev |
| Genzyme Corporation | $622.76 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $472.36 | 2023-2025 | Fasenra, Tezspire, Airsupra |
| Regeneron Healthcare Solutions, INC. | $391.29 | 2023-2025 | Dupixent |
| Intuitive Surgical, INC. | $221.27 | 2023-2024 | Da Vinci Surgical System |
| Actelion Pharmaceuticals US, INC. | $167.88 | 2023-2024 | Opsumit, Uptravi |
| Baxter Healthcare | $159.89 | 2023-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Insmed, INC. | $159.88 | 2025 | Arikayce, Brinsupri |
| Amgen INC. | $152.13 | 2022-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $139.86 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $136.47 | 2023-2024 | |
| La Jolla Pharmaceutical Company | $94.20 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.02 | 2022 | |
| Grifols USA, LLC | $69.33 | 2023-2024 | Prolastin-C Liquid |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $54.28 | 2024 | |
| Merck Sharp & Dohme LLC | $53.05 | 2024-2025 | Winrevair |
| Janssen Biotech, INC. | $41.76 | 2023 | |
| Electromed, INC. | $24.64 | 2025 | Smartvest |
| Fisher & Paykel Healthcare INC | $17.52 | 2024 | Fisher & Paykel Healthcare |
| Philips North America LLC | $15.12 | 2024 | (Ak6) Vest Therapy |
| Alexion Pharmaceuticals, INC. | $14.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ishaq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.